The 21st century has ushered in a new age where all aspects of our lives are impacted by technology. How will humanity anticipate, mitigate, and manage the consequences of AI, robots, quantum computing and more? How do we ensure tech works for the good of all? This Ashoka series sheds light on the wisdom and ideas of leaders in the field.
Dr. Stephen Friend is a globally acclaimed serial entrepreneur and biomedical researcher. He currently is the President and co-founder of 4YouandMe, a visiting Professor of Connected Medicine at Oxford University and Chairman of the Board of Directors of Sage Bionetworks, where he was co-founder and President. He previously held positions at Apple, was Senior Vice President at Merck & Co, founded and led Rosetta Impharmatics, and was an Associate Professor at Harvard Medical School. He was elected an Ashoka Fellow in 2011. Before venturing into medicine and cancer research, he studied anthropology and philosophy.
Konstanze Frischen (Ashoka): Stephen, how can AI help us live healthier?
Stephen Friend: It’s simple: Wearable devices – rings or watches that register heartbeat and all kinds of other physiological data – today can allow individuals to follow themselves. But the potential is bigger: What we are betting on is that we can use AI and machine learning to analyze these data in ways that better track stress and individual symptoms so we can forecast the onset or worsening of chronic diseases like migraines, MS, Crohn’s disease, or even vulnerable times of metamorphosis, like pregnancy or menopause.
KF: And what are you learning?
SF: We are learning how to collect multidimensional, longitudinal data on chronic illnesses – and the results are remarkably strong. An individual’s physiological data – variable heart rate, breathing patterns, skin tone, and much more – yield patterns that correlate with flares of symptoms. And we are setting up studies to test if the more centered a person is in themselves, the lesser the degree of their illness. Conversely, we can see that stress is a breeding ground for symptoms.
KF: So, the data generated by wearables show that our states of mind like stress or wellbeing are underpinned by physiological markers that correspond to diseases?
SF: Yes, this is what we expect to verify. The signals are numerous, and in unison. The body has a way of responding to stress that changes your voice, blood pressure, sleep, what’s going on in your pancreas, your sweat and so on. And the ability to pick these data sets up and stick all of them together, means we can get a pretty good idea of how someone is doing and can start to make individual forecasts for a patient when a disease is likely to start or flare up.
Image Credit: New York Times
News This Week
Omicron subvariant BA.2 – which was dominant worldwide early this year, including in Hong Kong – replicates more swiftly than other strains and causes faster programmed cell death in human brains, a new study has found. [...]
The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of [...]
Blood pressure is a key vital sign that provides insight into our cardiovascular health. But blood pressure is typically measured only a few times per year by a clinician—and these measurements might not always [...]
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]
Over the years, researchers have tried hard to comprehend topographic signals that promote cell mechanical sensitive responses. The extracellular matrix (ECM) provides a complex cellular microenvironment that controls cellular behavior. Nevertheless, only a few [...]
There is now an imminent threat of measles spreading in various regions globally, as COVID-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the World Health Organization (WHO) [...]
In a recent study, it was shown that people with long Covid have had physical changes to their brains several months after experiencing the initial infection. The study included MRIs of patients who continued [...]
Western University in London, Ont., is building a unique research lab to study humanity's greatest viral threats — a secret weapon, if you will, one that it's expected would put Canada and the world in a better position if [...]
Cancer patients are testing a medicine made of antibodies that were designed from scratch on a computer in Israel and whose inventor has “programmed” them to “decide” whether cells surrounding tumors are bad or good. [...]
In an article published in the journal Scientific Reports, researchers presented the potentiostatic deposition used to electrodeposit nickel (Ni) and nickel-graphene (Ni-G) films on copper substrates. Myristic acid (MA) was employed to alter the plane of the [...]
Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability. Faculty from the OSU College of Pharmacy spearheaded a collaboration [...]